Top

Published in:

01-12-2019 | Vulvovaginal Candidiasis | Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz and M Pereira, Section Editors)

Update of Vulvovaginal Candidiasis in Pregnant and Non-pregnant Patients

Authors: Tito Ramírez-Lozada, Víctor Manuel Espinosa-Hernández, María Guadalupe Frías-De-León, Erick Martínez-Herrera

Published in: Current Fungal Infection Reports | Issue 4/2019

Abstract

Purpose of the Review

Candida albicans vulvovaginitis is one of the most frequent symptomatic infections in women and its incidence increases in reproductive age and pregnancy. Currently there are more specific and sensitive tests to identify Candida species that are resistant to antifungal agents, such as PCR and MALDI TOF MS, in order to improve prognosis.

Recent Findings

The genus Candida is part of the microbiota in humans; however, many species can become pathogenic. Vulvovaginitis caused by non-albicans Candida are becoming very important due to their high levels of antifungal resistance, which makes treatment difficult. Therefore, in addition to using phenotypic, biochemical tests, molecular analyses should be used to improve diagnosis and give appropriate treatment.

Summary

Both in childhood and in reproductive age, women are exposed to several episodes of vulvovaginitis, mainly due to bacteria and fungi, due to various risk factors. Among the fungi, the most common agent is Candida albicans and within the non-albicans is Candida glabrata, but there are other species related to greater resistance and recurrence.

• Guinot M, Blanco JE, Delgado JL, et al. Acceptability, tolerability, and effects on symptoms and signs of vulvovaginitis of a non-soap, herbal-based intimate hygiene solution (Zelesse). J Int Med Res. 2019;47:2626–36. https://doi.org/10.1177/0300060519837820This paper report general aspects ofCandidavulvovaginitis.CrossRefPubMedPubMedCentral

•• Loveless M, Myint O. Vulvovaginitis- presentation of more common problems in pediatric and adolescent gynecology. Best Pract Res Clin Obstet Gynaecol. 2017:1–14. https://doi.org/10.1016/j.bpobgyn.2017.08.014This paper report aspects of epidemiology and causal agents ofCandidavulvovaginitis.CrossRef

•• Babic M, Hukic M. Candida albicans and non-albicans species as etiological agent of vaginitis in pregnant and non-pregnant women. Bosn J BASIC Med Sci. 2010;10:89–97 This paper report aspects of epidemiology and causal agents ofCandidavulvovaginitis.CrossRefPubMedPubMedCentral

•• Goje O, Munoz JL. Vulvovaginitis: Find the cause to treat it. Cleve Clin J Med. 2017;84:215–24. https://doi.org/10.3949/ccjm.84a.15163This paper report aspects of epidemiology causal Treatment ofCandidavulvovaginitis.CrossRefPubMed

• Paladine HL, Desai UA. Vaginitis: Diagnosis and Treatment. Am Fam Physician. 2018;97:321–9 This paper report aspects of treatment forCandidavulvovaginitis.PubMed

Donders GGG, Sobel JD. Candida vulvovaginitis: A store with a buttery and a show window. Mycoses. 2017;60(2):70–2. https://doi.org/10.1111/myc.12572.CrossRefPubMed

•• De Bernardis F, Graziani S, Tirelli F, et al. Candida vaginitis: virulence, host response and vaccine prospects. Med Mycol. 2018;56:26–31. https://doi.org/10.1093/mmy/myx139This article refers to the pathophysiology ofCandidavulvovaginitis.CrossRefPubMed

• Martin Lopez JE. Candidiasis (vulvovaginal). 2015;3:1–23 This paper report general aspects ofCandidavulvovaginitis.

Felix TC, de Brito Röder DVD, Dos Santos Pedroso R. Alternative and complementary therapies for vulvovaginal candidiasis. Folia Microbiol. 2019;64(2):133–41. https://doi.org/10.1007/s12223-018-0652-x.CrossRef

10.

Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214:15–21. https://doi.org/10.1016/j.ajog.2015.06.067.CrossRefPubMed

11.

•• Rodríguez-Cerdeira C, Gregorio MC, Molares-vila A, et al. Biofilms and vulvovaginal candidiasis. Colloids Surfaces B Biointerfaces. 2019;174:110–25. https://doi.org/10.1016/j.colsurfb.2018.11.011This article refers to the pathophysiology and causal agents ofCandidavulvovaginitis.CrossRefPubMed

12.

Dermendzhiev T, Hadzhieva K, Dermendzhiev S. Analysis of clinical and microbiological indicators of vulvovaginal candidiasis. Biotechnol Equip. 2016;30:1173–8.CrossRef

13.

•• van Schalkwyk J, Yudin MH. Vulvovaginitis: Screening for and Management of Trichomoniasis, Vulvovaginal Candidiasis, and Bacterial vaginosis. J Obstet Gynaecol Canada. 2015;37:266–74. https://doi.org/10.1016/S1701-2163(15)30316-9This paper report aspects of treatment forCandidavulvovaginitis.CrossRef

14.

• Dovnik A, Golle A, Novak D, et al. Treatment of vulvovaginal candidiasis: a review of the literature. Acta Dermatovenerol APA. 2015;24:5–7 This paper report aspects of treatment forCandidavulvovaginitis.CrossRef

15.

Aggarwal A, Wadhwa R, Kapoor D, et al. High Prevalence of Genital Mycotic Infections with Sodium - glucose Co - transporter 2 Inhibitors among Indian Patients with Type 2 Diabetes. Indian J Endocrinol Metab. 2019;23:9–13. https://doi.org/10.4103/ijem.IJEM_244_18.CrossRefPubMedPubMedCentral

16.

• Neuman H, Koren O. The Pregnancy Microbiome. Nestlé Nutr Inst Work Ser. 2017;88:1–9. https://doi.org/10.1159/000455207This article refers to the pathophysiology ofCandidavulvovaginitis.CrossRef

17.

• Roberts CL, Algert CS, Rickard KL, et al. Treatment of vaginal candidiasis for the prevention of preterm birth : a systematic review and meta-analysis. Syst Rev. 2015;4:3–9. https://doi.org/10.1186/s13643-015-0018-2This paper report aspects of treatment forCandidavulvovaginitis.CrossRef

18.

Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome : new information about genital tract flora using molecular based techniques. BJOG An Int J Obstet Gynaecol. 2011;118:533–49. https://doi.org/10.1111/j.1471-0528.2010.02840.x.CrossRef

19.

Valenti P, Rosa L, Capobianco D, et al. Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense. Front immnulogy. 2018;9:1–14. https://doi.org/10.3389/fimmu.2018.00376.CrossRef

20.

Amabebe E, Anumba DOC. The Vaginal Microenvironment : The Physiologic Role of Lactobacilli. Front immnulogy. 2018;5:1–11. https://doi.org/10.3389/fmed.2018.00181.CrossRef

21.

• Anderson MZ, Bennett RJ. Budding off: bringing functional genomics to Candida albicans. Brief Funct Genomics. 2016;15:85–94. https://doi.org/10.1093/bfgp/elv035This article refers to the pathophysiology ofCandidavulvovaginitis.CrossRefPubMed

22.

Vila T, Romo JA, Pierce CG, et al. Targeting Candida albicans filamentation for antifungal drug development. Virulence. 2017;8:150–8. https://doi.org/10.1080/21505594.2016.1197444.CrossRefPubMed

23.

•• Lohse MB, Gulati M, Johnson AD, et al. Development and regulation of single-and multi-species Candida albicans biofilms. Nat Rev Microbiol. 2018;16:19–31. https://doi.org/10.1038/nrmicro.2017.107This paper refers to the pathophysiology ofCandidavulvovaginitis.CrossRefPubMed

24.

• Naglik JR, Hube B, Gaffen SL, et al. Candida albicans-epithelial interactions and induction of mucosal innate immunity. Curr Opin Microbiol. 2018;40:104–12. https://doi.org/10.1016/j.mib.2017.10.030This article refers to the pathophysiology ofCandidavulvovaginitis.CrossRef

25.

Verma-gaur J, Traven A. Microreview Post-transcriptional gene regulation in the biology and virulence of Candida albicans. Cel Microbiol. 2016;18:800–6. https://doi.org/10.1111/cmi.12593.CrossRef

26.

•• Miró MS, Rodríguez E, Vigezzi C, et al. Candidiasis vulvovaginal : una antigua enfermedad con nuevos desafíos. Rev Iberoam Micol. 2017;34:65–71 This article refers to the pathophysiology ofCandidavulvovaginitis.CrossRefPubMed

27.

• Cavalheiro M, Teixeira MC. Candida Biofilms: Threats, Challenges, and Promising Strategies. Front Med. 2018;5:1–15. https://doi.org/10.3389/fmed.2018.00028This article refers to the pathophysiology ofCandidavulvovaginitis.CrossRef

28.

Nobile CJ, Johnson AD. Candida albicans Biofilms and Human Disease. Annu Rev Microbiol. 2015;69:71–92. https://doi.org/10.1146/annurev-micro-091014-104330.CrossRefPubMedPubMedCentral

29.

Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10:2–11. https://doi.org/10.1038/s41419-019-1413-8.CrossRef

30.

Castilho D, Alencar Chaves AF, Valente Navarro M, et al. Secreted aspartyl proteinase (PbSap) contributes to the virulence of Paracoccidioides brasiliensis infection. PLoS Negl Trop Dis. 2018:1–21. https://doi.org/10.1371/journal.pntd.0006806.CrossRefPubMedPubMedCentral

31.

Bradford LL, Ravel J. The vaginal mycobiome: A contemporary perspective on fungi in women’s health and diseases. Virulence. 2017;8:342–51. https://doi.org/10.1080/21505594.2016.1237332.CrossRefPubMed

32.

Kim J, Park S, Lee J. Epigenetic Control of Oxidative Stresses by Histone Acetyltransferases in Candida albicans. J Microbiol Biotechnol. 2018;28:181–9. https://doi.org/10.4014/jmb.1707.07029.CrossRefPubMed

33.

• Ruiz-sánchez BP, Cruz-zárate D, Estrada-garcía I, et al. Innate lymphoid cells and their role in immune response regulation. Rev Alerg Mex. 2017;64:347–63 This article refers to the pathophysiology ofCandidavulvovaginitis.PubMed

34.

Miramon P, Lorenz M. A feast for Candida: Metabolic plasticity confers an edge for virulence. PLoS Negl Trop Dis. 2017;13:1–7. https://doi.org/10.1371/journal.ppat.1006144.CrossRef

35.

Yano J, Peters BM, Noverr MC, et al. Novel Mechanism behind the Immunopathogenesis of vulvovaginal Candidiasis ‘Neutrophil Anergy’. Am Soc Microbiol. 2018;86:1–12. https://doi.org/10.1128/IAI.00684-17.CrossRef

36.

Kroon SJ, Ravel J, Huston WM. Cervicovaginal microbiota, women’s health, and reproductive outcomes. Fertil Steril. 2018;110:327–36.CrossRefPubMed

37.

Goyal S, Castrillon-Betancur JC, Klaile E, et al. The interaction of Human Pathogenic Fungi with C-Type Lectin Receptors. Front immunology. 2018;9:1–25. https://doi.org/10.3389/fimmu.2018.01261.CrossRef

38.

Montaño Estrada LF, Fortoul T, der Goes V, et al. Qué son los inflamosomas? El NLRP3 como ejemplo. Rev la Fac Med la UNAM. 2016;60:42–9.

39.

da Silva DA, Lee KK, Raziunaite I, et al. Cell biology of Candida albicans – host interactions. Curr Opin Microbiol. 2016;34:111–8.CrossRef

40.

Nuriel-Ohayon M, Neuman H, Koren O. Microbial Changes during Pregnancy, Birth, and Infancy. Front Microbiol. 2016;7:1–13. https://doi.org/10.3389/fmicb.2016.01031.CrossRef

41.

• Yu F, Hu Z, Lin X. Analysis of the Vaginal Microecological Status and Genital Tract Infection Characteristics of 751 Pregnant Women. Med Sci Monit. 2018;24:5338–45. https://doi.org/10.12659/MSM.909051This paper report general aspects ofCandidavulvovaginitis.CrossRefPubMedPubMedCentral

42.

•• Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Women’s Heal. 2019;19:1–9. https://doi.org/10.1186/s12905-019-0748-8This paper report general aspects ofCandidavulvovaginitis.CrossRef

43.

Hong E, Dixit S, Sci BM, et al. Vulvovaginal Candidiasis as a Chronic Disease: Diagnostic Criteria and Definition. J Low Genit Tract Dis. 2014;18:31–8.CrossRefPubMed

44.

Pineda-Murillo J, Cortés-figueroa A, del NJ U-BT, et al. Candidosis vaginal. Revisión de la literatura y situación de México y otros países latinoamericanos. Rev Med Risaralda. 2017;23:38–44.

45.

Makanjuola O, Bongomin F. An Update on the Roles of Non- albicans Candida Species in Vulvovaginitis. J fungi. 2018;4:2–17. https://doi.org/10.3390/jof4040121.CrossRef

46.

Thulkar J, Kriplani A, Agarwal N. Utility of pH test & Whiff test in syndromic approach of abnormal vaginal discharge. Indian J Med Res. 2010;131:445–8.PubMed

47.

Sobel JD, Akins RA. The Role of PCR in the Diagnosis of Candida Vulvovaginitis — a New Gold Standard? Curr Infect Dis Rep. 2015;17:1–5.CrossRef

48.

Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961–71. https://doi.org/10.1007/s11908-015-0488-3.CrossRefPubMed

49.

•• Marot-leblond A, Nail-billaud S, Beucher B, et al. Efficient Diagnosis of Vulvovaginal Candidiasis by Use of a New Rapid Immunochromatography Test. J Clin Microbiol. 2009;47:3821–5. https://doi.org/10.1128/JCM.01168-09This paper reports aspects diagnostic methods forCandidavulvovaginitis.CrossRefPubMedPubMedCentral

50.

• Aniebue U, Nwankwo T, Nwafor M. Vulvovaginal Candidiasis in Reproductive Age Women in Enugu Nigeria, Clinical versus Laboratory-assisted Diagnosis. Niger J Clin Pract. 2018;21:1017–22. https://doi.org/10.4103/njcp.njcp_25_16This paper reports aspects diagnostic methods forCandidavulvovaginitis.CrossRefPubMed

51.

• Posteraro B, Efremov L, Leoncini E, et al. Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy. J Clin Microbiol. 2015;53:2439–50. https://doi.org/10.1128/JCM.00802-15This paper reports aspects diagnostic methods forCandidavulvovaginitis.CrossRefPubMedPubMedCentral

52.

Reyes-Montes MR, Acosta-altamirano G, Duarte-Escalante E, et al. Usefulness of a multiplex PCR for the rapid identification of Candida glabrata species complex in Mexican clinical isolates. J Sao Paulo Inst Trop Med. 2019;61:1–7. https://doi.org/10.1590/S1678-9946201961037.CrossRef

53.

•• Byun SW, Park YJ, Hur SY. Affirm VPIII microbial identification test can be used to detect Gardnerella vaginalis, Candida albicans and trichomonas vaginalis microbial infections in Korean women. J Obs Gynaecol Res. 2016;42:422–6. https://doi.org/10.1111/jog.12913This paper reports aspects diagnostic methods forCandidavulvovaginitis.CrossRef

54.

•• Tardif KD, Schlaberg R, Tardif K, et al. Development of a Real-Time PCR Assay for the Direct Detection of Candida species Causing Vulvovaginal Candidiasis. Diagnostic Microbiol Infect Dis. 2017. https://doi.org/10.1016/j.diagmicrobio.2017.01.012This paper reports aspects diagnostic methods forCandidavulvovaginitis.CrossRefPubMed

55.

Schwebke JR, Gaydos CA, Nyirjesy P, et al. Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis. J Clin Microbiol. 2018;56:1–13. https://doi.org/10.1128/JCM.00252-18.CrossRef

56.

• Al-ameri NO, Al-Sa’adi AH, Habeed RA. Detection of ERG11-2 gene in Candida spp. which resistant to some antifungal agents by Real Time – PCR Detection of ERG11-2 gene in Candida spp. which resistant to some antifungal agents by Real Time – PCR. J Nat Sci Res. 2017;4:2–10 This paper mentions aspects diagnostic methods forCandidavulvovaginitis.CrossRef

57.

•• Aguirre-quiñonero A. Accuracy of the BD MAX TM vaginal panel in the diagnosis of infectious vaginitis. Eur J Clin Microbiol Infect Dis. 2018. https://doi.org/10.1007/s10096-019-03480-8This paper mentions aspects diagnostic methods forCandidavulvovaginitis.CrossRef

58.

•• Gaydos CA, Beqaj S, Schwebke JR, et al. Clinical Validation of a Test for the Diagnosis of Vaginitis. Obs Gynecol. 2017;130:181–9. https://doi.org/10.1097/AOG.0000000000002280This paper mentions aspects diagnostic methods forCandidavulvovaginitis.CrossRef

59.

•• Obstet AG, Li C, Wang L, et al. Microsatellite analysis of genotype distribution patterns of Candida albicans vulvovaginal candidiasis in Nanjing, China and its association with pregnancy, age and clinical presentation. Arch Gynecol Obstet. 2016. https://doi.org/10.1007/s00404-016-4029-6This paper mentions clinical aspects ofCandidavulvovaginitis.CrossRefPubMed

60.

• Alizadeh M, Kolecka A, Boekhout T, et al. Identification of Candida species isolated from vulvovaginitis using matrix assisted laser desorption ionization-time of flight mass spectrometry. Curr Med Mycol. 2017;3:21–5. https://doi.org/10.29252/cmm.3.4.21This paper mentions aspects diagnostic methods forCandidavulvovaginitis.CrossRefPubMedPubMedCentral

61.

Muhleisen AL. Herbst-kralovetz MM. Maturitas: Menopause and the Vaginal Microbiome; 2016.

62.

Marnach ML, Torgerson RR. Vulvovaginal Issues in Mature Women. Mayo Clin Proc. 2017;92:449–54. https://doi.org/10.1016/j.mayocp.2016.10.031.CrossRefPubMed

63.

Matthews N, Wong V, Brooks J, et al. Genital Diseases in the Mature. Clin Dermatol. 2018;36(2):208–21. https://doi.org/10.1016/j.clindermatol.2017.10.012.CrossRefPubMed

Title: Update of Vulvovaginal Candidiasis in Pregnant and Non-pregnant Patients
Authors: Tito Ramírez-Lozada
Víctor Manuel Espinosa-Hernández
María Guadalupe Frías-De-León
Erick Martínez-Herrera
Publication date: 01-12-2019
Publisher: Springer US
Keywords: Vulvovaginal Candidiasis
Candida Balanitis
Candida Albicans
Respiratory Microbiota
Published in: Current Fungal Infection Reports / Issue 4/2019
Print ISSN: 1936-3761
Electronic ISSN: 1936-377X
DOI: https://doi.org/10.1007/s12281-019-00357-3

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of the Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2019

From Culture to Fungal Biomarkers: the Diagnostic Route of Fungal Infections in Children with Primary Immunodeficiencies

Updates on the Treatment of Non-Aspergillus Hyaline Mold Infections

Tinea Gladiatorum: an Update

Chromoblastomycosis in Solid Organ Transplant Recipients

Fungal Necrotizing Skin and Soft Tissue Infections

Genetic Variation and Fungal Infection Risk: State of the Art

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage